Supplementary Data from Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor–Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti–HER2-Based TherapyTomás Pascual,Aranzazu Fernandez-Martinez,Maki Tanioka, M. Vittoria Dieci,Sonia Pernas,Joaquin Gavila,Valentina Guarneri,Javier Cortes,Patricia Villagrasa,Núria Chic, Maria Vidal,Barbara Adamo,Montserrat Muñoz,Gaia Griguolo,Antonio Llombart,Pierfranco Conte,Mafalda Oliveira,Benedetta Conte,Laia Paré,Patricia Galvan,Lisa A. Carey,Charles M. Perou,Aleix Pratcrossref（2024）引用 0|浏览3暂无评分摘要Supplementary Data更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
